CARLSBAD, Calif.--(www.businesswire.com/">BUSINESS WIRE)--Geneuity, a leader in the integration of molecular diagnostics and pathology testing for pharma, contract research organizations, and medical device companies, today announced that it is expanding early access to Thermo Fisher Scientifics targeted, next-generation ...
MPLN is a medical diagnostics firm that provides anatomic pathology, flow cytometry, fluorescence in situ hybridization and cytogenetic testing services.